Abciximab
Sulfasalazine may increase the anticoagulant activities of Abciximab.
Acebutolol
Sulfasalazine may decrease the antihypertensive activities of Acebutolol.
Aceclofenac
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Aceclofenac.
Advertisement
Acemetacin
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Acemetacin.
Acenocoumarol
Sulfasalazine may increase the anticoagulant activities of Acenocoumarol.
Acetyl salicylate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Acetylsalicylic acid.
Advertisement
Aclarubicin
Sulfasalazine may decrease the excretion rate of Aclarubicin which could result in a higher serum level.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Sulfasalazine.
Alclometasone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Alclometasone.
Advertisement
Aldosterone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Aldosterone.
Alendronate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Alendronic acid.
Alendronic acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Alendronic acid.
Aliskiren
Sulfasalazine may decrease the antihypertensive activities of Aliskiren.
Alminoprofen
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Alminoprofen.
Alprenolol
Sulfasalazine may decrease the antihypertensive activities of Alprenolol.
Alprostadil
The therapeutic efficacy of Alprostadil can be decreased when used in combination with Sulfasalazine.
Amcinonide
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Amcinonide.
Amikacin
Sulfasalazine may decrease the excretion rate of Amikacin which could result in a higher serum level.
Amiloride
Sulfasalazine may decrease the antihypertensive activities of Amiloride.
Ancrod
Sulfasalazine may increase the anticoagulant activities of Ancrod.
Androstenedione
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Androstenedione.
Anhydrous Tacrolimus
Sulfasalazine may increase the nephrotoxic activities of Tacrolimus.
Antipyrine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Antipyrine.
Antithrombin III
Sulfasalazine may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Sulfasalazine may increase the anticoagulant activities of Antithrombin III human.
Apalutamide
The serum concentration of Sulfasalazine can be decreased when it is combined with Apalutamide.
Apazone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Azapropazone.
Apixaban
Sulfasalazine may increase the anticoagulant activities of Apixaban.
Apremilast
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Apremilast.
Arbekacin
Sulfasalazine may decrease the excretion rate of Arbekacin which could result in a higher serum level.
Ardeparin
Sulfasalazine may increase the anticoagulant activities of Ardeparin.
Argatroban
Sulfasalazine may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Sulfasalazine may increase the anticoagulant activities of Argatroban.
Aspirin
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Acetylsalicylic acid.
Atenolol
Sulfasalazine may decrease the antihypertensive activities of Atenolol.
Azelastine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Azelastine.
azficel-T
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Azficel-T.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Sulfasalazine.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Sulfasalazine.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Sulfasalazine.
Azosemide
The therapeutic efficacy of Azosemide can be decreased when used in combination with Sulfasalazine.
Balsalazide
Sulfasalazine may increase the nephrotoxic activities of Balsalazide.
Becaplermin
Sulfasalazine may increase the anticoagulant activities of Becaplermin.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Beclomethasone dipropionate.
Benazepril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Benazepril.
Bendroflumethiazide
The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Sulfasalazine.
Benzydamine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Benzydamine.
Betamethasone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Betamethasone.
Betaxolol
Sulfasalazine may decrease the antihypertensive activities of Betaxolol.
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Sulfasalazine.
Bimatoprost
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Sulfasalazine.
Bisoprolol
Sulfasalazine may decrease the antihypertensive activities of Bisoprolol.
Bivalirudin
Sulfasalazine may increase the anticoagulant activities of Bivalirudin.
Bopindolol
Sulfasalazine may decrease the antihypertensive activities of Bopindolol.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Sulfasalazine.
Budesonide
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Budesonide.
Bufexamac
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Bufexamac.
Bumetanide
The therapeutic efficacy of Bumetanide can be decreased when used in combination with Sulfasalazine.
Bupranolol
Sulfasalazine may decrease the antihypertensive activities of Bupranolol.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Sulfasalazine.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Sulfasalazine.
Captopril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Captopril.
Carboprost
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Sulfasalazine.
Carboprost Tromethamine
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Sulfasalazine.
Carprofen
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Carprofen.
Carteolol
Sulfasalazine may decrease the antihypertensive activities of Carteolol.
Carvedilol
Sulfasalazine may decrease the antihypertensive activities of Carvedilol.
Celecoxib
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Celecoxib.
Celiprolol
Sulfasalazine may decrease the antihypertensive activities of Celiprolol.
Certoparin
Sulfasalazine may increase the anticoagulant activities of Certoparin.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Sulfasalazine.
Chlorothiazide
The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Sulfasalazine.
Chlorthalidone
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Sulfasalazine.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Sulfasalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Choline magnesium trisalicylate.
Ciclesonide
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ciclesonide.
Cilazapril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Cilazapril.
Cinoxacin
Sulfasalazine may increase the neuroexcitatory activities of Cinoxacin.
Citric Acid
Sulfasalazine may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Sulfasalazine may increase the anticoagulant activities of Citric Acid.
Clobetasol
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Clobetasol.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Clobetasol propionate.
Clobetasone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Clobetasone.
Clocortolone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Clocortolone.
Clodronic Acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Clodronic Acid.
Clonixin
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Clonixin.
Colesevelam
Colesevelam can cause a decrease in the absorption of Sulfasalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Sulfasalazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Cortisone acetate.
Curcumin
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Curcumin.
Cyclopenthiazide
The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Sulfasalazine.
Cyclosporine
Sulfasalazine may increase the nephrotoxic activities of Cyclosporine.
Dabigatran Etexilate
Sulfasalazine may increase the anticoagulant activities of Dabigatran etexilate.
Dalteparin
Sulfasalazine may increase the anticoagulant activities of Dalteparin.
Danaparoid
Sulfasalazine may increase the anticoagulant activities of Danaparoid.
Daunorubicin
Sulfasalazine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Deferasirox
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Deferasirox.
Deflazacort
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Deflazacort.
Desirudin
Sulfasalazine may increase the anticoagulant activities of Desirudin.
Desmopressin
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Desmopressin.
Desonide
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Desonide.
Desoximetasone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Desoximetasone.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Desoxycorticosterone acetate.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Desoxycorticosterone Pivalate.
Dexamethasone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Dexamethasone.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Sulfasalazine.
Dextran
Sulfasalazine may increase the anticoagulant activities of Dextran.
Dextran 40
Sulfasalazine may increase the anticoagulant activities of Dextran 40.
Dextran 70
Sulfasalazine may increase the anticoagulant activities of Dextran 70.
Dextran 75
Sulfasalazine may increase the anticoagulant activities of Dextran 75.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Sulfasalazine.
Dicumarol
Sulfasalazine may increase the anticoagulant activities of Dicoumarol.
Diflorasone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Diflorasone.
Diflucortolone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Difluocortolone.
Diflunisal
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Diflunisal.
Difluprednate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Difluprednate.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Sulfasalazine.
Dihydrostreptomycin
Sulfasalazine may decrease the excretion rate of Dihydrostreptomycin which could result in a higher serum level.
Dinoprost
The therapeutic efficacy of Dinoprost can be decreased when used in combination with Sulfasalazine.
Dinoprost Tromethamine
The therapeutic efficacy of Dinoprost Tromethamine can be decreased when used in combination with Sulfasalazine.
Dinoprostone
The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Sulfasalazine.
Dipyrone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Metamizole.
Doxorubicin
Sulfasalazine may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Doxorubicin Hydrochloride
Sulfasalazine may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Drospirenone
Sulfasalazine may increase the hyperkalemic activities of Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Droxicam.
Edetic Acid
Sulfasalazine may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Sulfasalazine may increase the anticoagulant activities of Edoxaban.
Eltrombopag
The serum concentration of Sulfasalazine can be increased when it is combined with Eltrombopag.
Enalapril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Enalaprilat.
Enoxacin
Sulfasalazine may increase the neuroexcitatory activities of Enoxacin.
Enoxaparin
Sulfasalazine may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Sulfasalazine may increase the anticoagulant activities of Enoxaparin.
Epirubicin
Sulfasalazine may decrease the excretion rate of Epirubicin which could result in a higher serum level.
Eplerenone
Sulfasalazine may decrease the antihypertensive activities of Eplerenone.
Epoprostenol
The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Sulfasalazine.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Sulfasalazine.
Esmolol
Sulfasalazine may decrease the antihypertensive activities of Esmolol.
Estrone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Sulfasalazine.
Ethacrynate
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Sulfasalazine.
Ethacrynic Acid
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Sulfasalazine.
Ethylenediaminetetraacetate
Sulfasalazine may increase the anticoagulant activities of Edetic Acid.
Etidronate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Etidronic acid.
Etidronic Acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Etidronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Etodolac.
Etofenamate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Etofenamate.
Etoricoxib
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Etoricoxib.
Evening primrose oil
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Evening primrose oil.
Felbinac
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Felbinac.
Fenbufen
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fenbufen.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Sulfasalazine.
Ferulic Acid
Sulfasalazine may increase the anticoagulant activities of Ferulic acid.
Fleroxacin
Sulfasalazine may increase the neuroexcitatory activities of Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Sulfasalazine.
Fludrocortisone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fludrocortisone.
Fluindione
Sulfasalazine may increase the anticoagulant activities of Fluindione.
Flumequine
Sulfasalazine may increase the neuroexcitatory activities of Flumequine.
Flumethasone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Flumethasone.
Flunisolide
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Flunisolide.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Flunisolide.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fluocinolone Acetonide.
Fluocinonide
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fluocinonide.
Fluocortolone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fluocortolone.
Fluorometholone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fluorometholone.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fluprednidene.
Fluprednisolone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fluprednisolone.
Flurandrenolide
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Flurandrenolide.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Sulfasalazine.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fluticasone furoate.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fluticasone propionate.
Folate
The serum concentration of Folic Acid can be decreased when it is combined with Sulfasalazine.
Folic Acid
The serum concentration of Folic Acid can be decreased when it is combined with Sulfasalazine.
Fondaparinux
Sulfasalazine may increase the anticoagulant activities of Fondaparinux.
Fondaparinux sodium
Sulfasalazine may increase the anticoagulant activities of Fondaparinux sodium.
Formestane
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Formestane.
Fosinopril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fosinopril.
Framycetin
Sulfasalazine may decrease the excretion rate of Framycetin which could result in a higher serum level.
Furosemide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Sulfasalazine.
Gatifloxacin
Sulfasalazine may increase the neuroexcitatory activities of Gatifloxacin.
Gatifloxacin Anhydrous
Sulfasalazine may increase the neuroexcitatory activities of Gatifloxacin.
Gemeprost
The therapeutic efficacy of Gemeprost can be decreased when used in combination with Sulfasalazine.
Gemifloxacin
Sulfasalazine may increase the neuroexcitatory activities of Gemifloxacin.
Gemifloxacin Mesylate
Sulfasalazine may increase the neuroexcitatory activities of Gemifloxacin.
Gentamicin
Sulfasalazine may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Grepafloxacin
Sulfasalazine may increase the neuroexcitatory activities of Grepafloxacin.
Halcinonide
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Halcinonide.
Halobetasol
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ulobetasol.
Haloperidol
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Haloperidol.
Heparin
Sulfasalazine may increase the anticoagulant activities of Heparin.
Hydralazine
Sulfasalazine may decrease the antihypertensive activities of Hydralazine.
Hydrochlorothiazide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Sulfasalazine.
Hydrocortisone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Sulfasalazine.
Ibandronate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ibandronate.
Ibandronic Acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ibandronate.
Ibuprofen
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ibuprofen.
Icatibant
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Icatibant.
Idarubicin
Sulfasalazine may decrease the excretion rate of Idarubicin which could result in a higher serum level.
Iloprost
The therapeutic efficacy of Iloprost can be decreased when used in combination with Sulfasalazine.
Imidapril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Imidapril.
Indapamide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Sulfasalazine.
Indobufen
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Indobufen.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Sulfasalazine.
Irbesartan
The risk or severity of adverse effects can be increased when Irbesartan is combined with Sulfasalazine.
Isavuconazole
The serum concentration of Sulfasalazine can be increased when it is combined with Isavuconazole.
Kanamycin
Sulfasalazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.
kanamycin A
Sulfasalazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.
Kebuzone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Kebuzone.
Ketoprofen
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ketoprofen.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Sulfasalazine.
Labetalol
Sulfasalazine may decrease the antihypertensive activities of Labetalol.
Latanoprost
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Sulfasalazine.
Latanoprostene Bunod
The therapeutic efficacy of Latanoprostene Bunod can be decreased when used in combination with Sulfasalazine.
Leflunomide
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Leflunomide.
Lepirudin
Sulfasalazine may increase the anticoagulant activities of Lepirudin.
Levobunolol
Sulfasalazine may decrease the antihypertensive activities of Levobunolol.
Levofloxacin
Sulfasalazine may increase the neuroexcitatory activities of Levofloxacin.
Levofloxacin Anhydrous
Sulfasalazine may increase the neuroexcitatory activities of Levofloxacin.
Limonene, (+)-
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with (4R)-limonene.
Lisinopril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Lisinopril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Sulfasalazine.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Sulfasalazine.
Lornoxicam
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Lornoxicam.
Losartan
The risk or severity of adverse effects can be increased when Losartan is combined with Sulfasalazine.
Loteprednol
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Loteprednol.
Loxoprofen
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Loxoprofen.
Lubiprostone
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Sulfasalazine.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Magnesium salicylate.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Sulfasalazine.
Mecamylamine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Mecamylamine.
Meclofenamate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Meclofenamic acid.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Meclofenamic acid.
Medronate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Technetium Tc-99m medronate.
Medrysone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Medrysone.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Sulfasalazine.
Meloxicam
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Meloxicam.
Mesalamine
Sulfasalazine may increase the nephrotoxic activities of Mesalazine.
Methotrexate
Sulfasalazine may increase the hepatotoxic activities of Methotrexate.
Methyclothiazide
The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Sulfasalazine.
Methylprednisolone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Methylprednisolone.
Metipranolol
Sulfasalazine may decrease the antihypertensive activities of Metipranolol.
Metolazone
The therapeutic efficacy of Metolazone can be decreased when used in combination with Sulfasalazine.
Metoprolol
Sulfasalazine may decrease the antihypertensive activities of Metoprolol.
Metrizamide
Sulfasalazine may decrease the excretion rate of Metrizamide which could result in a higher serum level.
Misoprostol
The therapeutic efficacy of Misoprostol can be decreased when used in combination with Sulfasalazine.
Moexipril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Moexipril.
Mometasone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Mometasone.
Morniflumate
The risk or severity of adverse effects can be increased when Morniflumate is combined with Sulfasalazine.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Mycophenolic acid.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Sulfasalazine.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Mycophenolic acid.
Nabumetone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Nabumetone.
Nadolol
Sulfasalazine may decrease the antihypertensive activities of Nadolol.
Nadroparin
Sulfasalazine may increase the anticoagulant activities of Nadroparin.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Sulfasalazine.
Nalidixic Acid
Sulfasalazine may increase the neuroexcitatory activities of Nalidixic Acid.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Sulfasalazine.
Nebivolol
Sulfasalazine may decrease the antihypertensive activities of Nebivolol.
Neomycin
Sulfasalazine may decrease the excretion rate of Neomycin which could result in a higher serum level.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Sulfasalazine.
Netilmicin
Sulfasalazine may decrease the excretion rate of Netilmicin which could result in a higher serum level.
Niflumic Acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Niflumic Acid.
Nimesulide
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Nimesulide.
Norfloxacin
Sulfasalazine may increase the neuroexcitatory activities of Norfloxacin.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Evening primrose oil.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Sulfasalazine.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Sulfasalazine.
Olsalazine
Sulfasalazine may increase the nephrotoxic activities of Olsalazine.
Omacetaxine Mepesuccinate
The risk or severity of bleeding can be increased when Sulfasalazine is combined with Omacetaxine mepesuccinate.
Oxaprozin
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Oxaprozin.
Oxprenolol
Sulfasalazine may decrease the antihypertensive activities of Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Oxyphenbutazone.
Pamidronate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Pamidronate.
Pamidronic Acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Pamidronate.
Paramethasone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Paramethasone.
Parecoxib
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Parecoxib.
Paromomycin
Sulfasalazine may decrease the excretion rate of Paromomycin which could result in a higher serum level.
Parthenolide
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Parthenolide.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Sulfasalazine.
Pefloxacin
Sulfasalazine may increase the neuroexcitatory activities of Pefloxacin.
Penbutolol
Sulfasalazine may decrease the antihypertensive activities of Penbutolol.
Pentaerythritol Tetranitrate
Sulfasalazine may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentosan Polysulfate
Sulfasalazine may increase the anticoagulant activities of Pentosan Polysulfate.
Perindopril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Perindopril.
Phenindione
Sulfasalazine may increase the anticoagulant activities of Phenindione.
Phenprocoumon
Sulfasalazine may increase the anticoagulant activities of Phenprocoumon.
Phenylbutazone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Phenylbutazone.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Sulfasalazine.
Pindolol
Sulfasalazine may decrease the antihypertensive activities of Pindolol.
Pirarubicin
Sulfasalazine may decrease the excretion rate of Pirarubicin which could result in a higher serum level.
Piretanide
The therapeutic efficacy of Piretanide can be decreased when used in combination with Sulfasalazine.
Pirfenidone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Pirfenidone.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Sulfasalazine.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Sulfasalazine.
Plicamycin
Sulfasalazine may decrease the excretion rate of Plicamycin which could result in a higher serum level.
Polythiazide
The therapeutic efficacy of Polythiazide can be decreased when used in combination with Sulfasalazine.
Practolol
Sulfasalazine may decrease the antihypertensive activities of Practolol.
Pralatrexate
The serum concentration of Pralatrexate can be increased when it is combined with Sulfasalazine.
Prasterone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Prasterone.
Prednicarbate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Prednicarbate.
Prednisolone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Prednisolone.
Prednisone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Prednisone.
Pregnenolone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Pregnenolone.
Probenecid
The serum concentration of Sulfasalazine can be increased when it is combined with Probenecid.
Propranolol
Sulfasalazine may decrease the antihypertensive activities of Propranolol.
protein C, human
Sulfasalazine may increase the anticoagulant activities of Protein C.
protein S, human
Sulfasalazine may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Sulfasalazine may increase the anticoagulant activities of Protocatechualdehyde.
Quinapril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Quinapril.
Quinethazone
The therapeutic efficacy of Quinethazone can be decreased when used in combination with Sulfasalazine.
Ramipril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ramipril.
Rescinnamine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Rescinnamine.
Resveratrol
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Resveratrol.
Reviparin
Sulfasalazine may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Sulfasalazine may increase the anticoagulant activities of Reviparin.
Rimexolone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Rimexolone.
Risedronate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Risedronate.
Risedronic Acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Risedronate.
Rivaroxaban
Sulfasalazine may increase the anticoagulant activities of Rivaroxaban.
Rofecoxib
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Rofecoxib.
Rolapitant
The serum concentration of Sulfasalazine can be increased when it is combined with Rolapitant.
Rosoxacin
Sulfasalazine may increase the neuroexcitatory activities of Rosoxacin.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Sulfasalazine.
Salicylamide
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Salicylamide.
Salicylic Acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Salicylic acid.
Salsalate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Salsalate.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Sulfasalazine.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Sulfasalazine.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Serrapeptase.
Sisomicin
Sulfasalazine may decrease the excretion rate of Sisomicin which could result in a higher serum level.
Sodium Phosphate
Sodium phosphate may increase the nephrotoxic activities of Sulfasalazine.
Sodium Phosphate, Monobasic
Sodium phosphate may increase the nephrotoxic activities of Sulfasalazine.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Sodium phosphate may increase the nephrotoxic activities of Sulfasalazine.
Sotalol
Sulfasalazine may decrease the antihypertensive activities of Sotalol.
Sparfloxacin
Sulfasalazine may increase the neuroexcitatory activities of Sparfloxacin.
Spectinomycin
Sulfasalazine may decrease the excretion rate of Spectinomycin which could result in a higher serum level.
Spirapril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Spirapril.
Spironolactone
Sulfasalazine may decrease the antihypertensive activities of Spironolactone.
Streptomycin
Sulfasalazine may decrease the excretion rate of Streptomycin which could result in a higher serum level.
Streptozocin
Sulfasalazine may decrease the excretion rate of Streptozocin which could result in a higher serum level.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Sulfasalazine.
Suprofen
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Suprofen.
Tacrolimus
Sulfasalazine may increase the nephrotoxic activities of Tacrolimus.
Tafluprost
The therapeutic efficacy of Tafluprost can be decreased when used in combination with Sulfasalazine.
Talinolol
Sulfasalazine may decrease the antihypertensive activities of Talinolol.
Talniflumate
The risk or severity of adverse effects can be increased when Talniflumate is combined with Sulfasalazine.
Technetium Tc 99m Medronate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Technetium Tc-99m medronate.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Sulfasalazine.
Temafloxacin
Sulfasalazine may increase the neuroexcitatory activities of Temafloxacin.
Tenofovir Disoproxil
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Tenofovir disoproxil.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Sulfasalazine.
Teriflunomide
The serum concentration of Sulfasalazine can be increased when it is combined with Teriflunomide.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Tiaprofenic acid.
Tiludronate
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Tiludronic acid.
Tiludronic Acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Tiludronic acid.
Timolol
Sulfasalazine may decrease the antihypertensive activities of Timolol.
Timolol Anhydrous
Sulfasalazine may decrease the antihypertensive activities of Timolol.
Tixocortol
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Tixocortol.
Tobramycin
Sulfasalazine may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Tolfenamic Acid.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Sulfasalazine.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Sulfasalazine.
Torsemide
The therapeutic efficacy of Torasemide can be decreased when used in combination with Sulfasalazine.
Trandolapril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Trandolapril.
Tranilast
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Tranilast.
Travoprost
The therapeutic efficacy of Travoprost can be decreased when used in combination with Sulfasalazine.
Treprostinil
The risk or severity of adverse effects can be increased when Treprostinil is combined with Sulfasalazine.
Triamcinolone
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Triamcinolone.
Triamterene
Sulfasalazine may decrease the antihypertensive activities of Triamterene.
Trichlormethiazide
The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Sulfasalazine.
Trovafloxacin
Sulfasalazine may increase the neuroexcitatory activities of Trovafloxacin.
Troxerutin
Sulfasalazine may increase the anticoagulant activities of Troxerutin.
UNOPROSTONE
The therapeutic efficacy of Unoprostone can be decreased when used in combination with Sulfasalazine.
Valdecoxib
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Valdecoxib.
Valrubicin
Sulfasalazine may decrease the excretion rate of Valrubicin which could result in a higher serum level.
Valsartan
The risk or severity of adverse effects can be increased when Valsartan is combined with Sulfasalazine.
Vancomycin
The serum concentration of Vancomycin can be increased when it is combined with Sulfasalazine.
Vemurafenib
The serum concentration of Vemurafenib can be decreased when it is combined with Sulfasalazine.
Warfarin
Sulfasalazine may increase the anticoagulant activities of Warfarin.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Sulfasalazine.
Zofenopril
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Zofenopril.
Zoledronic Acid
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Zoledronic acid.
Zoledronic Acid Anhydrous
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Zoledronic acid.
Zomepirac
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Zomepirac.
